LEADER 04288nam 22007815 450 001 9910416101503321 005 20230629202104.0 010 $a3-030-33946-7 024 7 $a10.1007/978-3-030-33946-3 035 $a(CKB)4100000011384181 035 $a(DE-He213)978-3-030-33946-3 035 $a(MiAaPQ)EBC6297566 035 $a(PPN)250216442 035 $a(EXLCZ)994100000011384181 100 $a20200811d2020 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAdvanced Concepts in Human Immunology: Prospects for Disease Control /$fedited by Pooja Jain, Lishomwa C. Ndhlovu 205 $a1st ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (XVIII, 403 p. 16 illus., 5 illus. in color.) 311 $a3-030-33945-9 327 $a1. Human Chronic Viruses: Pathogenesis, host response, and treatment -- 2. Defining the Role of Immunoproteomics in Human Immunotherapy -- 3. Microbiome and Cellular Players in Type 1 Diabetes: from Pathogenesis to Protection -- 4. Immune Mechanisms, Pathology, and Management of Allergic Ocular Diseases -- 5. Dendritic Cell-regulated T Cell Immunity and Tolerance against Acute Myeloid Leukemia -- 6. Perspectives on the Role of T cell Negative Immune Checkpoint Receptors in Health and Disease -- 7. Neuroprotective Immunity for Neurodegenerative and Neuroinfectious Diseases -- 8. Polycystic Ovary Syndrome: An overview of a complex, heterogeneous genetic condition. 330 $aThis book highlights information derived primarily from clinical samples, with particular reference to theoretical and scientific aspects of the human immune system. This text will focus on topics that range from host-pathogen interactions in infectious disease to host immune response in cancer, allergic diseases, neuroinflammatory diseases, and autoimmune disorders. The reader will also have a well-rounded understanding of the behavior of the immune system with particular emphasis on the role of immunoproteomics in immunotherapy, neuroprotective immunity for neurodegenerative and neuroinfectious disease, leukemia-associated dendritic cell induction of adaptive immunity dysregulation, and the role of immune checkpoint inhibitors in cancer, infection, as well as neuroinflammation. Taken together, the contents of this book are intended for both clinicians and researchers in academia and industry. 606 $aImmunology 606 $aVaccines 606 $aInfectious diseases 606 $aCancer research 606 $aImmunologia$2thub 606 $aSistema immunitari$2thub 606 $aMalalties autoimmunitàries$2thub 606 $aCàncer$2thub 606 $aAl·lèrgia$2thub 606 $aMalalties neurodegeneratives$2thub 606 $aMalalties infeccioses$2thub 606 $aImmunology$3https://scigraph.springernature.com/ontologies/product-market-codes/B14000 606 $aVaccine$3https://scigraph.springernature.com/ontologies/product-market-codes/B16010 606 $aInfectious Diseases$3https://scigraph.springernature.com/ontologies/product-market-codes/H33096 606 $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001 608 $aLlibres electrònics$2thub 615 0$aImmunology. 615 0$aVaccines. 615 0$aInfectious diseases. 615 0$aCancer research. 615 7$aImmunologia 615 7$aSistema immunitari 615 7$aMalalties autoimmunitàries 615 7$aCàncer 615 7$aAl·lèrgia 615 7$aMalalties neurodegeneratives 615 7$aMalalties infeccioses 615 14$aImmunology. 615 24$aVaccine. 615 24$aInfectious Diseases. 615 24$aCancer Research. 676 $a616.079 702 $aJain$b Pooja$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aNdhlovu$b Lishomwa C$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910416101503321 996 $aAdvanced Concepts in Human Immunology: Prospects for Disease Control$92509545 997 $aUNINA